← Back to catalogue
GEM Hemochron 100 Activated Clotting Time Plus Test (ACT+)
FDA UDIClass II (US FDA UDI)
Identity
- Trade Name
- GEM Hemochron 100 Activated Clotting Time Plus Test (ACT+) FDA UDI
- Generic Name
- Activated clotting time (ACT) IVD, reagent FDA UDI
- Device Name
- GH100 ACT+ 45 cuvettes/box. FDA UDI
- Model / Reference
- 000GACT+ FDA UDI
- Description
- GH100 ACT+ 45 cuvettes/box. FDA UDI
Identifiers
- Catalog Number
- 000GACT+ FDA UDI
- Primary DI / UDI-DI
- 10711234103401 FDA UDI
- 510(k) Number
- K202101 FDA UDI
- FDA Product Code
- JBP FDA UDI
- GMDN Term
- Activated clotting time (ACT) IVD, reagent FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 864.7140 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Activated clotting time (ACT) IVD, reagent
GEM Hemochron 100 Activated Clotting Time Plus Test (ACT+) by Accriva Diagnostics Holdings, Inc. — Class II — FDA UDI — listed in FDA GUDID
Similar devices
Also classified as Activated clotting time (ACT) IVD, reagent.
- C-ACT Tubes — Helena Laboratories, Corp. · Class II
- G-ACT Tubes — Helena Laboratories, Corp. · Class II
- TEG5000 HEMOSTASIS SYSTEM — HAEMONETICS CORPORATION · Class II
- Actalyke MAX-ACT Tubes — Helena Laboratories, Corp. · Class II
- K-ACT Tubes — Helena Laboratories, Corp. · Class II
- Hemochron Whole Blood Microcoagulation System — ACCRIVA DIAGNOSTICS HOLDINGS, INC. · Class II
- Hemochron Whole Blood Coagulation System — ACCRIVA DIAGNOSTICS HOLDINGS, INC. · Class II
- Hemochron Whole Blood Coagulation System — ACCRIVA DIAGNOSTICS HOLDINGS, INC. · Class II
Cleared under the same submission
K202101 also covers:
- GEM Hemochron 100 Low Range Activated Clotting Time Test (ACT-LR) — ACCRIVA DIAGNOSTICS HOLDINGS, INC.
- GEM Hemochron 100 System — ACCRIVA DIAGNOSTICS HOLDINGS, INC.
- directCHECK ACT+ Whole Blood Control Level 1 — ACCRIVA DIAGNOSTICS HOLDINGS, INC.
- directCHECK ACT+ Whole Blood Control, Level 2 — ACCRIVA DIAGNOSTICS HOLDINGS, INC.
- directCHECK ACT-LR Whole Blood Control, Level 2 — ACCRIVA DIAGNOSTICS HOLDINGS, INC.
- directCHECK ACT-LR Whole Blood Controls, Level 1 — ACCRIVA DIAGNOSTICS HOLDINGS, INC.
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Accriva Diagnostics Holdings, Inc.
Sources (1)
- FDA UDI 5b307035-2bcc-44b8-9a84-ff3b530445f7 37 fields · synced May 30, 2026